-
- 抗原 See all SHC1 抗体
- SHC1 (SHC (Src Homology 2 Domain Containing) Transforming Protein 1 (SHC1))
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This SHC1 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
- 纯化方法
- Purified from mouse ascites fluids by affinity chromatography
- 免疫原
- Full length human recombinant protein of human SHC1 (NP_003020) produced in HEK293T cell.
- 克隆位点
- 3A1
- 亚型
- IgG1
- Top Product
- Discover our top product SHC1 Primary Antibody
-
-
- 应用备注
- WB 1:2000, IHC 1:50, IF 1:100,
- 说明
-
The concentration of the product may vary between diferrent lots.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 0.5-1.0 mg/mL
- 缓冲液
- PBS ( pH 7.3) containing 1 % BSA, 50 % glycerol and 0.06 % sodium azide.
- 储存液
- Sodium azide
- 注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
Role of SNTA1 in Rac1 activation, modulation of ROS generation, and migratory potential of human breast cancer cells." in: British journal of cancer, Vol. 110, Issue 3, pp. 706-14, (2014) (PubMed).
: "
-
Role of SNTA1 in Rac1 activation, modulation of ROS generation, and migratory potential of human breast cancer cells." in: British journal of cancer, Vol. 110, Issue 3, pp. 706-14, (2014) (PubMed).
-
- 抗原
- SHC1 (SHC (Src Homology 2 Domain Containing) Transforming Protein 1 (SHC1))
- 别名
- SHC1 (SHC1 产品)
- 别名
- SHC1 antibody, SHC antibody, SHCA antibody, P66shc antibody, si:dkey-246i14.4 antibody, wu:fc10h03 antibody, shc antibody, p66shc antibody, Shc antibody, ShcA antibody, p66 antibody, SHC adaptor protein 1 antibody, Shc1p antibody, squalene--hopene cyclase antibody, SHC (Src homology 2 domain containing) transforming protein 1 antibody, SHC (Src homology 2 domain containing) transforming protein 1 L homeolog antibody, src homology 2 domain-containing transforming protein C1 antibody, SHC1 antibody, shc1 antibody, Shc1 antibody, shc1.L antibody
- 分子量
- 51.5 kDa
- 基因ID
- 6464
- NCBI登录号
- NM_003029
- HGNC
- 6464
- 途径
- RTK signaling, TCR Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, ER-Nucleus Signaling, Signaling Events mediated by VEGFR1 and VEGFR2
-